These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1421423)

  • 1. IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence.
    Brünner N; Moser C; Clarke R; Cullen K
    Breast Cancer Res Treat; 1992; 22(1):39-45. PubMed ID: 1421423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II).
    Brünner N; Yee D; Kern FG; Spang-Thomsen M; Lippman ME; Cullen KJ
    Eur J Cancer; 1993; 29A(4):562-9. PubMed ID: 8435211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T61 human breast cancer xenograft: an experimental model of estrogen therapy of breast cancer.
    Brunner N; Spang-Thomsen M; Cullen K
    Breast Cancer Res Treat; 1996; 39(1):87-92. PubMed ID: 8738608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.
    Daly RJ; Harris WH; Wang DY; Darbre PD
    Cell Growth Differ; 1991 Sep; 2(9):457-64. PubMed ID: 1661135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
    Fox EM; Miller TW; Balko JM; Kuba MG; Sánchez V; Smith RA; Liu S; González-Angulo AM; Mills GB; Ye F; Shyr Y; Manning HC; Buck E; Arteaga CL
    Cancer Res; 2011 Nov; 71(21):6773-84. PubMed ID: 21908557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice.
    Kahán Z; Varga JL; Schally AV; Rékási Z; Armatis P; Chatzistamou L; Czömpöly T; Halmos G
    Breast Cancer Res Treat; 2000 Mar; 60(1):71-9. PubMed ID: 10845811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and oncogene mediated growth regulation of human breast cancer cells.
    Kasid A; Lippman ME
    J Steroid Biochem; 1987; 27(1-3):465-70. PubMed ID: 3501040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
    Nickerson T; Chang F; Lorimer D; Smeekens SP; Sawyers CL; Pollak M
    Cancer Res; 2001 Aug; 61(16):6276-80. PubMed ID: 11507082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hormones on tumor growth, cell kinetics, estrogen receptor and insulin-like growth factor-I-related protein of human breast cancer (MCF-7) cells transplanted in nude mice.
    Noguchi M; Thomas M; Koyasaki N; Ohta N; Taniya T; Kitagawa H; Miyazaki I; Mizukami Y
    Mol Cell Endocrinol; 1993 Mar; 92(1):69-76. PubMed ID: 8472869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
    Jordan VC; Gottardis MM; Robinson SP; Friedl A
    J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
    Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model.
    Osborne CK; Ross CR; Coronado EB; Fuqua SA; Kitten LJ
    Breast Cancer Res Treat; 1988 Jul; 11(3):211-9. PubMed ID: 3167228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of estrogen receptor expression in breast cancer.
    Martin MB; Saceda M; Lindsey RK
    Adv Exp Med Biol; 1993; 330():143-53. PubMed ID: 8368130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.